Stockreport

Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update

Traws Pharma, Inc.  (TRAW) 
PDF Completed acquisition of Trawsfynydd and concurrent $14 million Capital Raise Excellent pipeline progress, led by candidates for COVID 19, influenza, and oncology progr [Read more]